Weisheit Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 111.50%
(FY 2022)
- Profit 99.38%
(FY 2022)
- Ebitda 103.80%
(FY 2022)
- Net Worth -0.21%
(FY 2022)
- Total Assets 337.59%
(FY 2022)
About Weisheit Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajendra Mane, Neha Boob, and Rajkumar Boob serve as directors at the Company.
- CIN/LLPIN
U74995PN2019PTC183658
- Company No.
183658
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Apr 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Weisheit Healthcare Private Limited offer?
Weisheit Healthcare Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Health Supplement, Herbal Supplements, Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Anti Infective Drugs & Medicines, HIV Drugs, Mineral Supplement, Ayurvedic Pain Relief Oil.
Who are the key members and board of directors at Weisheit Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Mane  | Director | 17-Feb-2023 | Current |
| Neha Boob | Director | 22-Apr-2019 | Current |
| Rajkumar Boob | Director | 22-Apr-2019 | Current |
Financial Performance of Weisheit Healthcare.
Weisheit Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 111.5% increase. The company also saw a substantial improvement in profitability, with a 99.38% increase in profit. The company's net worth dipped by a decrease of 0.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Weisheit Healthcare?
In 2021, Weisheit Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Weisheit Healthcare?
Unlock and access historical data on people associated with Weisheit Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Weisheit Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Weisheit Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
